We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Laser Scattering Technique Detects Single Molecules

By LabMedica International staff writers
Posted on 21 Sep 2014
Print article
Image: Investigators identified individual unlabeled proteins by the weak shadow that the biomolecules produce when they scatter laser light (Photo courtesy of the Max Planck Institute for the Science of Light).
Image: Investigators identified individual unlabeled proteins by the weak shadow that the biomolecules produce when they scatter laser light (Photo courtesy of the Max Planck Institute for the Science of Light).
A recent paper described a novel technique for the label-free detection of single biomolecules such as tumor markers, proteins, or RNA fragments.

Investigators at the Max Planck Institute for the Science of Light (Erlangen, Germany) adapted a method called interferometric detection of scattering (iSCAT) to achieve the goal of label-free single molecule detection.

In this approach, which was described fully in the July 29, 2014, online edition of the journal Nature Communications, the investigators directed laser light onto a microscope slide on which proteins of interest had been captured with appropriate biochemical lures. The bound proteins scattered the laser light, thus casting a shadow. By comparing shadow diagrams before and after binding of the proteins of interest, the investigators could identify target proteins, which stood out clearly from the background as dark spots, even though the shadow of the protein was only one ten-thousandth or even one hundred-thousandth as dark as the background.

“In our method the scattering image of a protein is amplified and stripped of background noise. iSCAT not only promises more sensitive diagnosis of diseases such as cancers, but will also shed light on many fundamental biochemical processes in nature,” said senior author Dr. Vahid Sandoghdar, director of the nano-optics division of the Max Planck Institute for the Science of Light. “Until now it was thought that if you want to detect scattered light from nanoparticles, you have to eliminate all background light. However, in recent years we have realized that it is more advantageous to illuminate the sample strongly and visualize the feeble signal of a tiny nanoparticle as a shadow against the intense background light. The strength of our method lies not only in the fact that it is so sensitive and that we can count target proteins in a sample, iSCAT also shows us the exact position of particles.”

Related Links:

Max Planck Institute for the Science of Light


Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
New
Gold Member
Chagas Disease Test
CHAGAS Cassette
New
HSV-1 Test
Herpes Simplex Virus 1 Test
New
Hepatitis B Test
OnSite HBsAg Rapid Test

Print article

Channels

Molecular Diagnostics

view channel
Image: A coronal MRI section shows a high-intensity focused ultrasound lesion in the left thalamus of the brain (Photo courtesy of UT Southwestern Medical Center)

Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries

Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more

Immunology

view channel
Image: The discovery of biomarkers could improve endometrial cancer treatment (Photo courtesy of Mount Sinai)

Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer

Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.